Shares in Aerie Pharmaceuticals (NSDQ:AERI) fell slightly today after the company missed earnings expectations on Wall Street with its third quarter results.
The Irvine, Calif.-based company posted a net loss of -$32.4 million, or -89¢ per share, for the 3 months ended Sept. 30, for bottom-line loss of -36% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Aerie Pharmaceuticals misses EPS estimates by 7 cents in Q3 appeared first on MassDevice.
from MassDevice http://ift.tt/2hXVvpA
Cap comentari:
Publica un comentari a l'entrada